and the Heart HaroId Aukema Rotimi AIuko Human NutritionaI Sciences University of Manitoba Canadian Hemp Trade AIIiance NationaI Hemp Convention Winnipeg, November 17, 2009 Outline Ìmportance of kidneys and chronic kidney disease Dietary approaches to slowing kidney disease progression Effects of hemp protein isolate on progression of chronic kidney disease Effects on the heart Why are kidneys so important? They do 3 essential things: Regulate water Remove wastes Produce hormones that regulate: the uptake of calcium from the intestine blood pressure the making of red blood cells Chronic Kidney Disease Affects 2 miIIion Canadians Kidneys faiI in 14 more Canadians every day 34,000 on RRT in 2006 Expected to doubIe in 10 years 40% had transpIant 60% on diaIysis 70% of those on transpIant waiting Iist need kidneys (Dec 2007) National Kidney Foundation, 2009 USRDS 2008 ADR USRDS 2008 ADR Recognized CKD & ESRD in the NHANES & Medicare popuIations Figure p.1 (VoIume 1) NHANES: NHANES 1988-1994 & 1999-2006 participants, age 20 & older. Pati ent counts from 1988-1994 survey adjusted to 1990 U.S. population; counts from 1999-2006 survey adjusted to 2000 U.S. population. Medicare: general Medi care patients age 65 & older, surviving entire cohort year with Medicare as primary payor (& not enrolled in an HMO). ESRD patients excluded for CKD estimation; CKD defined by diagnosis codes. Risks associated with CKD Increased risk of kidney faiIure, CVD and death DiaIysis associated with: Reduced Iifespan (10 y for 42 year oId) 4 co morbidities per year 15 hospitaI days per year Lower quaIity of Iife NationaI Kidney Foundation, Am J Kidney Dis 39, S1-S256. Approaches to sIowing renaI disease progression Strict bIood gIucose controI in diabetes BIood pressure controI Dietary modifications - protein, Iipid, saIt Dietary Intervention on Chronic Kidney Disease 90 60 30 15 GIomeruIar FiItration Rate (GFR) MarginaI ESRD Moderate CKD Severe CKD Stage 1 5 4 3 2 120 Early treatment can make a difference 100 10 0 No Treatment Current Treatment Earl y Treatment 4 7 9 11 Time (years) Kidney Failure G F R ( m L / m i n / 1 . 7 3 2 ) Dietary Soy Protein in Kidney Disease Subtotally nephrectomized rats (Williams A. et al, 1987) db/db mice with type ÌÌ diabetic nephropathy (Teixeira S.R. et al, 2003) Aging Fischer 344 rats (Schimokawa I. et al, 1993; Iwasaki K. et al, 1988) Chronic nephrotic syndrome (Tovar et al 2002) pcy mice ÷ adolescent nephronophthisis (Tomobe K. et al 1998, Aukema H. et al 1999) Effects of Dietary Soy Protein on Glomerular Size in Obese fa/fa Zucker Rats In CTL In SOY fa CTL fa SOY 6 Wk of Dietary Soy Protein in weanling Han:SPRD-cy rats Casein Soy Protein Kidney Int 59: 52 Kidney Int 59: 52- -61, 2001 61, 2001 Effect of dietary soy protein on established kidney disease in Han:SPRD-cy rats Macrophages (ceIIs/video fieId) 0 10 20 Casein Soy Protein PCNA (ceIIs/video fieId) 0 10 20 30 Casein Soy Protein Oxidized LDL (fraction of section) 0 0.01 0.02 0.03 Casein Soy Protein *Soy protein reduces renal cell inflammation, proliferation and oxidative damage * * * P=0.0455 P=0.0059 0 0.005 0.01 0.015 0.02 Week 1 Week 3 MaIe F i b r o s i s
k i d n e y s Effect of protein source on heart size in rats with cystic kidneys Conclusions Ìn a model of chronic kidney disease, early treatment with dietary hemp protein: Maintains normal growth Reduces kidney pathology Ìmproves kidney function Reduces enlarged heart size Hemp protein could be part of an overall dietary approach to slowing down kidney disease and associated heart disease Acknowledgements Joy Gauthier Yong Jia Manon Roy Stephanie Caligiuri Eniko Kresz Natural Sciences and Engineering Research Council of Canada Effect of protein source on serum MCP-1 in rats with cystic kidneys